AP NEWS

Monoclonal Antibody Therapeutics: World Markets, 2023 -- Growing Consumption in Developing Countries - ResearchAndMarkets.com

November 23, 2018

DUBLIN--(BUSINESS WIRE)--Nov 23, 2018--The “Monoclonal Antibody Therapeutics Market by Application, by Source and by End Users: Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2023” report has been added to ResearchAndMarkets.com’s offering.

The report covers forecast and analysis for the monoclonal antibody therapeutics market on a global and regional level. The study provides historic data of 2015 to 2017 along with a forecast from 2018 to 2023 based on revenue (USD Billion).The study includes drivers and restraints for the monoclonal antibody therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the monoclonal antibody therapeutics market on a global level.The study provides a decisive view on the monoclonal antibody therapeutics market by segmenting the market based on application, source, end user and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2023.Based on application, the market is segmented into cancer, autoimmune diseases, infection, hematological diseases, and others. By source, the market is segmented into human, humanized, chimeric and others. Based on end users, the market is segmented into hospitals, private clinics and research institutes.The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East Africa with its further bifurcation into major countries including the U.S., UK, Germany, France, China, Japan, India, Brazil, etc. This segmentation includes demand for monoclonal antibody therapeutics market based on all segments in all the regions and countries.Market Dynamics Drivers Growing Monoclonal Antibody Therapeutics Consumption in Developing CountriesChanging Consumption Habits of Monoclonal Antibody Therapeutics Restraints High Taxation in Monoclonal Antibody Therapeutics Business and Trade Opportunities Innovative Products With Flavored Monoclonal Antibody Therapeutics

Key Topics Covered

1. Introduction

2. Executive Summary

3. Monoclonal Antibody Therapeutics Market - Market Dynamics

4. Global Monoclonal Antibody Therapeutics Market - Competitive Landscape

5. Global Monoclonal Antibody Therapeutics Market - Application Segment Analysis

6. Global Monoclonal Antibody Therapeutics Market - Source Segment Analysis

7. Global Monoclonal Antibody Therapeutics Market - End User Segment Analysis

8. Global Monoclonal Antibody Therapeutics Market - Regional Segment Analysis

9. Company ProfilesPfizer Inc.Bayer AGSanofiMerck Co. Inc.GlaxoSmithKline PLCF. Hoffmann-La Roche Ltd.Novartis AGAbbVie Inc.

For more information about this report visit https://www.researchandmarkets.com/research/nf4w7r/monoclonal?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181123005131/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biotechnology,Biopharmaceuticals

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/23/2018 07:40 AM/DISC: 11/23/2018 07:40 AM

http://www.businesswire.com/news/home/20181123005131/en

AP RADIO
Update hourly